Novartis wants every puff of its emphysema drug Onbrez to go into the cloud. The Swiss drugmaker has teamed up with U.S. technology firm Qualcomm to develop an internet-connected inhaler that can send information about how often it is used to remote computer servers known as the cloud. This kind of ...